Sveriges mest populära poddar
Bloomberg Intelligence
NyheterNäringsliv

Ennaid's Harrison on Developing Cure for the Zika Virus (Audio)

8 min•15 augusti 2016

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Intelligence

Visa alla avsnitt av Bloomberg Intelligence
Bloomberg Money: 'Gold Has Been in Bull Market for 25 Years'
•38 min
OpenAI’s Revenue Run Rate Tops $40 Billion Ahead of IPO
•22 min
Anthropic in Talks to Buy Startup Decart for $6 Billion
•25 min
CoreWeave Shares Soar After Booming AI Demand Boosts Outlook
•26 min
Apollo Inks $2.6 Billion Financing Deal With NY Yankees
•21 min
Intel to Sell $15 Billion in Stock After AI Boosts Demand
•22 min
Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase
•43 min
Under Armour Cuts Sales View on Softer Demand Around the World
•22 min
Warner Bros. Sales Fall on Loss of NBA, Weak Film Slate
•28 min
SpaceX’s $101 Billion Unlock Heaps Pressure on Battered Shares
•27 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.